Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway

Cancer Letters

Volumn 247, Issue 2, 2007, Pages 213-223

  Son, Se Hee ^a   Yu, Eunsil ^a   Ahn, Yeonsun ^a   Choi, Eun Kyung ^a   Lee, Heuiran ^a   Choi, Jene ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cell death; Promyelocytic leukemia protein; Retinoic acid; Ubiquitinylation

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEIN P21; RETINOIC ACID; UBIQUITIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN;

ADENOVIRIDAE;

EID: 33846926844     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.04.005     Document Type: Article

References (42)

1. Giguere V., Ong E.S., Segui P., and Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature 330 (1987) 624-629
2. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1 (2001) 181-193
3. Fontana J.A., and Rishi A.K. Classical and novel retinoids: their targets in cancer therapy. Leukemia 16 (2002) 463-472
4. Pitha-Rowe I., Petty W.J., Kitareewan S., and Dmitrovsky E. Retinoid target genes in acute promyelocytic leukemia. Leukemia 17 (2003) 1723-1730
5. de The H., Lavau C., Marchio A., Chomienne C., Degos L., and Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66 (1991) 675-684
6. Zhu J., Lallemand-Breitenbach V., and de The H. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission. Oncogene 20 (2001) 7257-7265
7. Rego E.M., Wang Z.G., Peruzzi D., He L.Z., Cordon-Cardo C., and Pandolfi P.P. Role of promyelocytic leukemia (PML) protein in tumor suppression. J. Exp. Med. 193 (2001) 521-529
8. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K., et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19 (2000) 6185-6195
9. Quignon F., De Bels F., Koken M., Feunteun J., Ameisen J.C., and de The H. PML induces a novel caspase-independent death process. Nat. Genet. 20 (1998) 259-265
10. Yang S., Kuo C., Bisi J.E., and Kim M.K. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat. Cell Biol. 4 (2002) 865-870
11. He D., Mu Z.M., Le X., Hsieh J.T., Pong R.C., Chung L.W., et al. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res. 57 (1997) 1868-1872
12. Le X.F., Vallian S., Mu Z.M., Hung M.C., and Chang K.S. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16 (1998) 1839-1849
13. Son S.H., Yu E., Choi E.K., Lee H., and Choi J. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells. Cancer Gene Ther. 12 (2005) 1-11
14. Manna S.K., and Aggarwal B.B. All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells. Oncogene 19 (2000) 2110-2119
15. Hammond L.A., Brown G., Keedwell R.G., Durham J., and Chandraratna R.A. The prospects of retinoids in the treatment of prostate cancer. Anticancer Drugs 13 (2002) 781-790
16. Simeone A.M., and Tari A.M. How retinoids regulate breast cancer cell proliferation and apoptosis. Cell Mol. Life Sci. 61 (2004) 1475-1484
17. Sheikh M.S., Shao Z.M., Chen J.C., Hussain A., Jetten A.M., and Fontana J.A. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem. 53 (1993) 394-404
18. Fitzgerald P., Teng M., Chandraratna R.A., Heyman R.A., and Allegretto E.A. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res. 57 (1997) 2642-2650
19. Schneider S.M., Offterdinger M., Huber H., and Grunt T.W. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res. 60 (2000) 5479-5487
20. Freemantle S.J., Spinella M.J., and Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22 (2003) 7305-7315
21. Ortiz M.A., Bayon Y., Lopez-Hernandez F.J., and Piedrafita F.J. Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. Drug Resist. Updat. 5 (2002) 162-175
22. Suh N., Lamph W.W., Glasebrook A.L., Grese T.A., Palkowitz A.D., et al. Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268. Clin. Cancer Res. 8 (2002) 3270-3275
23. Lee H., Kim J., Lee B., Chang J.W., Ahn J., Park J.O., et al. Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status. Int. J. Cancer 88 (2000) 454-463
24. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., et al. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2 (2000) 730-736
25. Brouillard F., and Cremisi C.E. Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells. J. Biol. Chem. 278 (2003) 39509-39516
26. Dow R., Hendley J., Pirkmaier A., Musgrove E.A., and Germain D. Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2. J. Biol. Chem. 276 (2001) 45945-45951
27. del Rincon S.V., Guo Q., Morelli C., Shiu H.Y., Sumacz E., and Miller W.H. Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism. Oncogene 23 (2004) 9269-9279
28. Cuadrado A., Garcia-Fernandez L.F., Gonzalez L., Suarez Y., Losada A., Alcaide V., et al. Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J. Biol. Chem. 278 (2003) 241-250
29. Pettersson F., Couture M.C., Hanna N., and Miller W.H. Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK. Oncogene 23 (2004) 7053-7066
30. Bernassola F., Salomoni P., Oberst A., Di Como C.J., Pagano M., Melino G., et al. Ubiquitin-dependent degradation of p73 is inhibited by PML. J. Exp. Med. 199 (2004) 1545-1557
31. Kambhampati S., Li Y., Verma A., Sassano A., Majchrzak B., Deb D.K., et al. Activation of protein kinase C delta by all-trans-retinoic acid. J. Biol. Chem. 278 (2003) 32544-32551
32. Salomoni P., and Pandolfi P.P. The role of PML in tumor suppression. Cell 108 (2002) 165-170
33. Spinella M.J., Freemantle S.J., Sekula D., Chang J.H., Christie A.J., and Dmitrovsky E. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J. Biol. Chem. 274 (1999) 22013-22018
34. Topisirovic I., Capili A.D., and Borden K.L. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner. Mol. Cell Biol. 22 (2002) 6183-6198
35. Rechsteiner M., and Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21 (1996) 267-271
36. Nervi C., Ferrara F.F., Fanelli M., Rippo M.R., Tomassini B., Ferrucci P.F., et al. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein. Blood 92 (1998) 2244-2251
37. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., et al. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193 (2001) 1361-1371
38. Boudjelal M., Voorhees J.J., and Fisher G.J. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells. Exp. Cell Res. 274 (2002) 130-137
39. Nawaz Z., Lonard D.M., Dennis A.P., Smith C.L., and O'Malley B.W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96 (1999) 1858-1862
40. Persons D.L., Yazlovitskaya E.M., and Pelling J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 275 (2000) 35778-35785
41. Bacus S.S., Gudkov A.V., Lowe M., Lyass L., Yung Y., Komarov A.P., et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20 (2001) 147-155
42. Le X.F., Marcelli M., McWatters A., Nan B., Mills G.B., O'Brian C.A., et al. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity. Oncogene 20 (2001) 8258-8269